CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
Ambulationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03636412
NCT03636412N/ACompleted

Improving Frailty With a Rigorous Ambulation Intervention in Lung Transplant Patients

The Cleveland Clinic·interventional·Posted Aug 17, 2018·Updated May 14, 2025

In Brief

A clinical study evaluating Ambulation for Transplant-Related Disorder and 4 related conditions. Completed, enrolled 200 participants across 1 site.

Detailed Summary

The objective of this study is to assess the feasibility and effectiveness of dedicated ambulator-assisted physical activity in lung transplant inpatients. The primary hypothesis is that an ambulator-assisted intervention for lung transplant patients will prove feasible and may result in improved frailty, hospital outcomes, including less need for inpatient rehabilitation and shorter length of stay in the hospital.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 17, 2018
Enrollment StartAug 15, 2018
Primary CompletionApr 15, 2024
Study CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 7.9 years ago

Interventions

Ambulationother

An ambulator will walk with a patient three times a day, based on physical therapy recommendations.